Viral Markers Screening Package

Viral Markers Screening Package is a critical diagnostic tool designed for the early detection and management of three of the most significant blood-borne viral infections: Hepatitis B, Hepatitis C, and HIV. These infections often remain asymptomatic for years, making proactive screening the only reliable way to ensure early intervention and prevent the unintentional spread of the viruses.

Hepatitis B HBsAg (Surface Antigen): This test identifies the presence of the Hepatitis B virus in the blood. As the earliest marker of an acute infection, it is also used to detect chronic carriers. Early detection of HBV is vital to prevent long-term liver complications such as cirrhosis or liver cancer.

Hepatitis C Anti-HCV Screening: This test looks for antibodies produced by the body in response to the Hepatitis C virus. Since Hep-C is often called a silent infection because it rarely shows symptoms in its early stages, this screening is essential for protecting liver health and accessing modern, highly effective curative treatments.

HIV 1 / HIV 2 Antibody Screening: This highly sensitive test screens for antibodies against both major types of the Human Immunodeficiency Virus. Knowing your status is the first step in accessing Antiretroviral Therapy (ART), which allows individuals with HIV to live long, healthy lives and reduces the risk of transmission to others.

This package is recommended for routine health checkups, pre-surgical evaluations, or for individuals who may have been exposed to risk factors such as blood transfusions, shared needles, or unprotected contact.